These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22781914)

  • 1. Circulating lymphocyte subsets in pancreatic adenocarcinoma and their relationship to the stage of the disease.
    Pezzilli R; Fabbri D; Imbrogno A; Morselli-Labate AM; Corinaldesi R
    Pancreas; 2012 Aug; 41(6):976-8. PubMed ID: 22781914
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal distribution of peripheral lymphocyte subsets induced by PDAC modulates overall survival.
    Xu YF; Lu Y; Cheng H; Shi S; Xu J; Long J; Liu L; Liu C; Yu X
    Pancreatology; 2014; 14(4):295-301. PubMed ID: 25062880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating CD4+CD25+ regulatory T cells in patients with pancreatic cancer.
    Yamamoto T; Yanagimoto H; Satoi S; Toyokawa H; Hirooka S; Yamaki S; Yui R; Yamao J; Kim S; Kwon AH
    Pancreas; 2012 Apr; 41(3):409-15. PubMed ID: 22158072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma.
    Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Sakai H; Fujita H; Nakata K; Tanaka M
    Ann Surg Oncol; 2010 Dec; 17(12):3120-8. PubMed ID: 20652642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.
    Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
    Ann Surg; 2012 Mar; 255(3):517-22. PubMed ID: 22301608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CD40-CD154 interaction would correlate with proliferation and immune escape in pancreatic ductal adenocarcinoma.
    Shoji Y; Miyamoto M; Ishikawa K; Yoshioka T; Mishra R; Ichinokawa K; Matsumura Y; Itoh T; Shinohara T; Hirano S; Kondo S
    J Surg Oncol; 2011 Mar; 103(3):230-8. PubMed ID: 21337550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori in autoimmune pancreatitis and pancreatic carcinoma.
    Jesnowski R; Isaksson B; Möhrcke C; Bertsch C; Bulajic M; Schneider-Brachert W; Klöppel G; Lowenfels AB; Maisonneuve P; Löhr JM
    Pancreatology; 2010; 10(4):462-6. PubMed ID: 20720447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of factors influencing recurrence and metastasis following curative resection of pancreatic ductal adenocarcinoma].
    Xie YB; Zhao P; Wang CF; Shan Y; Zhao DB; Liu Q; Bai XF
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):686-9. PubMed ID: 19173911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibody signature in human ductal pancreatic adenocarcinoma.
    Tomaino B; Cappello P; Capello M; Fredolini C; Ponzetto A; Novarino A; Ciuffreda L; Bertetto O; De Angelis C; Gaia E; Salacone P; Milella M; Nisticò P; Alessio M; Chiarle R; Giuffrida MG; Giovarelli M; Novelli F
    J Proteome Res; 2007 Oct; 6(10):4025-31. PubMed ID: 17824682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer.
    Smith RA; Bosonnet L; Ghaneh P; Sutton R; Evans J; Healey P; Garvey C; Hughes M; Raraty M; Campbell F; Neoptolemos JP
    Surgery; 2008 May; 143(5):658-66. PubMed ID: 18436014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN.
    Yamaguchi K; Kanemitsu S; Hatori T; Maguchi H; Shimizu Y; Tada M; Nakagohri T; Hanada K; Osanai M; Noda Y; Nakaizumi A; Furukawa T; Ban S; Nobukawa B; Kato Y; Tanaka M
    Pancreas; 2011 May; 40(4):571-80. PubMed ID: 21499212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of plasma Tu-M2-PK and CA19-9 in pancreatic cancer.
    Joergensen MT; Heegaard NH; Schaffalitzky de Muckadell OB
    Pancreas; 2010 Mar; 39(2):243-7. PubMed ID: 19820423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small invasive ductal adenocarcinoma of the pancreas associated with lymphoplasmacytic sclerosing pancreatitis.
    Motosugi U; Ichikawa T; Yamaguchi H; Nakazawa T; Katoh R; Itakura J; Fujii H; Sato T; Araki T; Shimizu M
    Pathol Int; 2009 Oct; 59(10):744-7. PubMed ID: 19788620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laminin gamma2-chain fragment circulating level increases in patients with metastatic pancreatic ductal cell adenocarcinomas.
    Katayama M; Funakoshi A; Sumii T; Sanzen N; Sekiguchi K
    Cancer Lett; 2005 Jul; 225(1):167-76. PubMed ID: 15922869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.
    Hiraoka N; Onozato K; Kosuge T; Hirohashi S
    Clin Cancer Res; 2006 Sep; 12(18):5423-34. PubMed ID: 17000676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of mast cell count following curative resection for pancreatic ductal adenocarcinoma.
    Cai SW; Yang SZ; Gao J; Pan K; Chen JY; Wang YL; Wei LX; Dong JH
    Surgery; 2011 Apr; 149(4):576-84. PubMed ID: 21167541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between different p53 expression patterns and chromosome 17 imbalances in pancreatic ductal adenocarcinoma based on tissue microarray analysis.
    Tsiambas E; Kravvaritis C; Tsounis D; Salemis NS; Niotis A; Niotis TH; Rigopoulos DN; Karameris A; Athanasiou AE; Patsouris E; Karakitsos P
    J BUON; 2010; 15(1):94-100. PubMed ID: 20414934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer.
    Novotný I; Dítĕ P; Dastych M; Záková A; Trna J; Novotná H; Nechutová H
    Hepatogastroenterology; 2008; 55(85):1475-7. PubMed ID: 18795715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extra-tumor perineural invasion predicts postoperative development of peritoneal dissemination in pancreatic ductal adenocarcinoma.
    Takahashi S; Hasebe T; Oda T; Sasaki S; Kinoshita T; Konishi M; Ueda T; Ochiai T; Ochiai A
    Anticancer Res; 2001; 21(2B):1407-12. PubMed ID: 11396223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.